Eclipse Aviation Corp.

Dr. Oliver Masefield joined Eclipse in 2000 and led the design and development of the Eclipse 500 jet prior to being named a Senior Fellow in 2004. Previously, Masefield was VP of Research and Development of Pilatus Aircraft, where he was responsible for technical innovation for Pilatus products worldwide. During his tenure at Pilatus, Masefield managed development and certification of the highly successful PC-12 corporate/utility aircraft as well as the development of the PC-7 and PC-9 military training aircraft. Before joining Pilatus in 1973, he was a Project Engineer on advanced Harrier V/STOL fighter aircraft for Hawker Siddeley Aircraft Ltd. Masefield holds a Bachelor of Technology degree in Aeronautical Engineering and a PhD in aerodynamics from the Loughborough University of Technology.

Prior to joining Eclipse, Jack Harrington was in private practice as an aviation lawyer since 1986. His aviation insurance experience is complemented by broad experience in general casualty and product liability insurance defense matters. Harrington is a member of the Lawyer-Pilots Bar Association, the Aviation Insurance Association, the National Business Aviation Association, the National Transportation Safety Board Bar Association, and the Experimental Aircraft Association, of which he is a director. He holds a commercial pilot certificate with airplane single-engine land and sea, multi-engine, and instrument airplane ratings.

Alfred E. Mann has been one of our directors since April 1999, our Chairman of the Board since December 2001 and our Chief Executive Officer since October 2003. He founded and formerly served as Chairman and Chief Executive Officer of MiniMed, Inc., a publicly traded company focused on diabetes therapy and microinfusion drug delivery that was acquired by Medtronic, Inc. in August 2001. Mr. Mann also founded and, from 1972 through 1992, served as Chief Executive Officer of Pacesetter Systems, Inc. and its successor, Siemens Pacesetter, Inc., a manufacturer of cardiac pacemakers, now the Cardiac Rhythm Management Division of St. Jude Medical Corporation. Mr. Mann founded and since 1993, has served as Chairman and until January 2008, as Co-Chief Executive Officer of Advanced Bionics Corporation, a medical device manufacturer focused on neurostimulation to restore hearing to the deaf and to treat chronic pain and other neural deficits, that was acquired by Boston Scientific Corporation in June 2004. In January 2008, the former stockholders of Advanced Bionics Corporation repurchased certain segments from Boston Scientific Corporation and formed Advanced Bionics LLC for cochlear implants and Infusion Systems LLC for infusion pumps. Mr. Mann is non-executive Chairman of both entities. Mr. Mann has also founded and is non-executive Chairman of Second Sight, which is developing a visual prosthesis for the blind and Quallion, which produces batteries for medical products and for the military and aerospace industries; and Stellar Microelectronics Inc., a supplier of electronic assemblies to the medical, military and aerospace industries. Mr. Mann is also non-executive Chairman of the Alfred Mann Foundation and Alfred Mann Institute at the University of Southern California, AMI Purdue and AMI Technion, and the Alfred Mann Foundation for Biomedical Engineering, which is establishing additional institutes at other research universities. Mr. Mann is also non-executive Chairman of the Southern California Biomedical Council, and a Director of the Nevada Cancer Institute and United Cerebral Palsy Foundation. Mr. Mann holds a bachelor’s and master’s degree in Physics from the University of California at Los Angeles, honorary doctorates from Johns Hopkins University, the University of Southern California, Western University and the Technion-Israel Institute of Technology and is a member of the National Academy of Engineering.

Brandon Jones has extensive experience in investment banking, securities law and private investing, and is currently co-head of private investments for Polygon Investment Partners LLP. Prior to joining Polygon in May 2004, Jones was senior vice president at Liberte' Investors, Inc., where he was responsible for sourcing, analyzing, and executing acquisitions. Before Liberte', Jones spent five years as an investment banker at Lehman Brothers and Thomas Weisel Partners. Jones began his career as a corporate M&A and securities lawyer at Baker Botts LLP.

On December 1, 2005, Kent Kresa was elected non-executive Chairman. Mr. Kresa presides at executive sessions of the Board. During 2008, the Board held five executive sessions with non-management directors only during regularly scheduled Board meetings, including one executive session with independent directors only. Stockholders and other interested parties may write to Mr. Kresa concerning matters other than accounting and auditing matters c/o Secretary, Avery Dennison Corporation, 150 North Orange Grove Boulevard, Pasadena, California 91103. Stockholders may also write to John T. Cardis, Chairman of the Audit Committee, regarding accounting and auditing matters c/o Secretary at the same address.